trial

Irish Omega-3 Study

NCTId NCT02848469
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Unknown
Enrollment 150 (estimated)
Sponsored by University College Cork
Primary completion 2018-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Unknown
Enrollment
150 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2013-09
Primary completion
2018-02
Eligibility
ALL · 13 Years · 45 Years

Interventions & indications

Drugs
1000mg of eicosapentaenoic acid and 1000mg docosahexaenoic acid

Sponsors

University College CorkLead Sponsor

Sites

1 total
Cork, Ireland

Linked catalysts

1
Irish Omega-3 Study — primary completion2018-02

Facts & assertions

4 sourced
Enrollment
150
Phase
PHASE2
Primary Completion Date
2018-02
Status
UNKNOWN
relationships
The graph out of here
drug
1000mg of eicosapentaenoic acid and 1000mg docosahexaenoic acid
drug
lead_sponsor
University College Cork
company
indication
Psychotic Disorders
indication
Psychotic Disorders
indication